Earlier this year, Dr. Kim was named among the nation’s top cancer leaders by Friends of Cancer Research, a national organization dedicated to advances in science, policy, and regulations that speed lifesaving treatments to patients.
Before joining City of Hope, Dr. Kim held leadership positions at the Levine Cancer Institute in North Carolina and University of Texas MD Anderson Cancer Center. He is among the country’s foremost experts in molecular prognostication for lung, head, and neck cancers, which greatly advances cancer detection and personalized therapies.
Dr. Kim has also been the principal and co-principal investigator on numerous studies and protocol. The author of more than 200 scientific articles, book chapters, and reviews in top-tier journals, his work is published in The Lancet, The Lancet Oncology, the Journal of Clinical Oncology, Cancer Discovery, Cancer, Clinical Cancer Research, and Cancer Prevention Research.